IMerge trial results led to FDA approval of IV Imetelstat for myelodysplastic syndrome (MDS) patients who've run out of standard treatment options. Learn more on the research here >>> https://t.co/bfU6UFzmeZ #PlainLanguageSummary #Hematology #RareBloodCancer

Interesting analysis suggests vagus nerve stimulation might work by boosting neurotransmitters to calm overactive brain circuits in epilepsy. Read the full research here 👇 https://t.co/w4cKIbq4pB #PlainLanguageSummary #Epilepsy #Neurotherapeutics

New study examines catheter lock solution to reduce deadly bloodstream infections in kidney disease patients on hemodialysis. Read the full research here >>> https://t.co/yw4PYObfEU #PlainLanguageSummary #KidneyDisease #Nephrology

New study examines potential fibrodysplasia ossificans progressiva (FOP) treatment and compares two bone imaging techniques for this rare genetic condition. https://t.co/Kk9PiC0dN6 #PLSP #RareDiseases

MonumenTAL-1 study shows how doctors managed talquetamab side effects in multiple myeloma patients. Learn more👇 https://t.co/7zxZOSpVhC #PlainLanguageSummary #MultipleMyeloma

New data highlights treatment transitions in atypical hemolytic uremic syndrome finding favorable safety outcomes and maintained disease control when patients transitioned to less frequent dosing option https://t.co/BSQMSjhw4n #PLSP #KidneyDisease

Interesting review looking at how palbociclib works for older breast cancer patients with HR+/HER2- disease. https://t.co/3PrnrCPuJX #PlainLanguageSummary #BreastCancer

Researchers evaluated an innovative cancer treatment for urothelial cancer patients who had limited options, it looked at effectiveness when standard treatments like cisplatin and immunotherapy weren't suitable https://t.co/qB1p3Api5U #PLSP #BladdercCancer

New plain language summary explores innovative approach to treating severe atopic dermatitis. Unlike existing therapies, this treatment targets the OX40 ligand immune pathway for patients needing alternatives to topical medications. https://t.co/4NsGSLCc3v #PLSP #Eczema

New treatment option for myelodysplastic syndrome, Imetelstat showed promise in Phase 3 trials for transfusion-dependent patients. Learn more on the research here >>> https://t.co/ZYK6je4oPM #PlainLanguageSummary #Hematology #RareBloodCancer

How does vagus nerve stimulation actually work for epilepsy? New research dives into the mechanisms behind this 30-year-old treatment. Read here 👇 https://t.co/KuQBzsKamB #PlainLanguageSummary #Epilepsy #Neurotherapeutics

LOCK IT-100 study tested whether taurolidine/heparin solution prevents serious bloodstream infections in dialysis patients. Read the full research here >>> https://t.co/uFya8VC3nJ #PlainLanguageSummary #KidneyDisease #Nephrology

New LUMINA-1 study tested garetosmab for fibrodysplasia ossificans progressiva (FOP), a rare condition where muscles turn to bone, plus evaluated bone imaging methods https://t.co/WlbKOlQkrr #PLSP #RareDiseases

New insights on managing talquetamab-related effects in multiple myeloma patients from MonumenTAL-1 trial. Learn more👇 https://t.co/BfR7DUgOB0 #PlainLanguageSummary #MultipleMyeloma

New analysis of palbociclib data for aging breast cancer patients with hormone receptor-positive disease. https://t.co/IijZihMPFD #PlainLanguageSummary #BreastCancer

Real-world evidence from Global aHUS Registry shows safe transition between two complement inhibitors for rare kidney disease. 60 patients switched treatments with stable disease markers and no need for dialysis or transplant, learn more👇 https://t.co/DtzwSifU2D #PLSP

Addressing unmet needs in eczema care, this clinical study evaluated a targeted antibody treatment for moderate-to-severe cases. Research focused on efficacy, safety, and duration of symptom control https://t.co/n3IrfMo74v #PlainLanguageSummary #EczemaResearch

This PLSP highlights targeted therapy research for locally advanced/metastatic bladder cancer. The study focused on Cohort 2 patients needing alternatives after immunotherapy progression and cisplatin intolerance https://t.co/tlzZLKUS7E #PLSP #BladdercCancer

New meta-analysis examines safety data from over 20K participants across 4 clinical trials. Study evaluated adverse events in patients with type 2 diabetes, heart failure, and chronic kidney disease.. Read here >> https://t.co/njqkMfOfqE #PLSP #DiabetesResearch

What happens when immunotherapy stops working? Research examines alternative treatment for metastatic urothelial cancer patients with FGFR2/3 mutations. Read the full summary here👇 https://t.co/cZbSUt6Ogw #PlainLanguageSummary #BladderCancer